BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ma ZY, Gong YF, Zhuang HK, Zhou ZX, Huang SZ, Zou YP, Huang BW, Sun ZH, Zhang CZ, Tang YQ, Hou BH. Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management. World J Gastroenterol 2020; 26(19): 2305-2322 [PMID: 32476795 DOI: 10.3748/wjg.v26.i19.2305]
URL: https://www.wjgnet.com/1948-5182/full/v26/i19/2305.htm
Number Citing Articles
1
Nina Vasilyevna Lyubimova, Yu. S. Timofeev, A. A. Markovich, A. V. Lebedeva, E. I. Karamisheva, V. V. Delektorskaya, N. E. Kushlinskii. Chromogranin B in blood serum of patients with neuroendocrine tumorsRussian Clinical Laboratory Diagnostics 2022; 67(8): 440 doi: 10.51620/0869-2084-2022-67-8-440-443
2
Hirotaka Ishida, Alfred King-yin Lam. Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classificationCritical Reviews in Oncology/Hematology 2022; 172: 103648 doi: 10.1016/j.critrevonc.2022.103648
3
N. V. Lyubimova, Yu. S. Timofeev, A. V. Lebedeva, N. E. Kushlinskii. Сравнительное исследование хромогранина А и хромогранина В у больных с нейроэндокринными опухолями желудка и поджелудочной железыAdvances in Molecular Oncology 2021; 8(3): 8 doi: 10.17650/2313-805X-2021-8-3-8-13
4
Costanza Chiapponi, Christiane J Bruns. Moderne molekulare und bildgebende Diagnostik bei neuroendokrinen Neoplasien des PankreasDie Chirurgie 2022; 93(8): 731 doi: 10.1007/s00104-022-01645-4
5
Tulan Hu, Wei Wang, Chiyi He, Cristina Magi-Galluzzi. Second Primary Malignancies in Patients with Pancreatic Neuroendocrine Neoplasms: A Population-Based Study on Occurrence, Risk Factors, and PrognosisJournal of Oncology 2021; 2021: 1 doi: 10.1155/2021/1565089
6
Wenzel M. Hackeng, Hussein A. Assi, Florine H.M. Westerbeke, Lodewijk A.A. Brosens, Christopher M. Heaphy. Prognostic and Predictive Biomarkers for Pancreatic Neuroendocrine TumorsSurgical Pathology Clinics 2022; 15(3): 541 doi: 10.1016/j.path.2022.05.007
7
Tara Keihanian, Mohamed Othman. Hepato-Pancreato-Biliary Malignancies2022; : 623 doi: 10.1007/978-3-030-41683-6_36
8
Shruti Gupta, Atul Kumar, Kiran Kumar Tejavath. A pharmacognostic approach for mitigating pancreatic cancer: emphasis on herbal extracts and phytoconstituentsFuture Journal of Pharmaceutical Sciences 2021; 7(1) doi: 10.1186/s43094-021-00246-y
9
Aman Chauhan, Alexandre Prieur, Jill Kolesar, Susanne Arnold, Léa Payen, Younes Mahi, Berengere Vire, Madison Sands, B. Mark Evers, Dominique Joubert, Lowell Anthony. hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine TumorsCancers 2022; 14(4): 863 doi: 10.3390/cancers14040863
10
Ryuta Muraki, Yoshifumi Morita, Kyota Tatsuta, Shinya Ida, Ryo Kitajima, Amane Hirotsu, Makoto Takeda, Hirotoshi Kikuchi, Yoshihiro Hiramatsu, Atsuko Fukazawa, Go Kuroda, Keisuke Kakizawa, Hiroya Takeuchi. Refractory postoperative Staphylococcus hominis bacteremia in a patient with an ACTH-producing pancreatic neuroendocrine neoplasm: a case reportSurgical Case Reports 2022; 8(1) doi: 10.1186/s40792-022-01485-8
11
Tara Keihanian, Mohamed Othman. Hepato-Pancreato-Biliary Malignancies2021; : 1 doi: 10.1007/978-3-030-37482-2_36-1
12
Marta Opalińska, Anna Sowa-Staszczak, Helena Olearska, Magdalena Ulatowska-Bialas, Aleksandra Gilis-Januszewska, Alicja Hubalewska-Dydejczyk. Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian TeratomaFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.770266
13
Bor-Shiuan Shyr, Bor-Uei Shyr, Shih-Chin Chen, Yi-Ming Shyr, Shin-E Wang. Impact of tumor grade on pancreatic neuroendocrine tumorsAsian Journal of Surgery 2022;  doi: 10.1016/j.asjsur.2022.01.094
14
Jiake Xu, Jie Yang, Ye Feng, Jie Zhang, Yuqiao Zhang, Sha Chang, Jingqiang Jin, Xia Du. MRI Feature-Based Nomogram Model for Discrimination Between Non-Hypervascular Pancreatic Neuroendocrine Tumors and Pancreatic Ductal AdenocarcinomasFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.856306
15
Antonio Viúdez, Guillermo Crespo, María Luisa Gómez Dorronsoro, Imanol Arozarena, Juan Jesús Marín-Méndez, Ana Custodio, Marta Benavent, Saioa Goñi, Beatriz García-Paredes, Jorge Hernando, Maika Durantez, Vicente Alonso, María del Carmen Riesco, Carlos López, Paula Jiménez-Fonseca, Borja López San Vicente, Iranzu González-Borja, Isabel Sevilla, Irene Hernández-Garcia, Alberto Carmona-Bayonas, Jaume Capdevila, Jairo Pérez-Sanz, Rocío García-Carbonero, Leyre Pérez-Ricarte, Marta Llanos, Ruth Vera, Ana De Jesús Acosta. Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimusPancreatology 2021; 21(1): 215 doi: 10.1016/j.pan.2020.12.009
16
Hebin Wang, Ding Ding, Tingting Qin, Hang Zhang, Jun Liu, Junfang Zhao, Chien-Hui Wu, Ammar Javed, Christopher Wolfgang, Shiwei Guo, Qingmin Chen, Weihong Zhao, Wei Shi, Feng Zhu, Xingjun Guo, Xu Li, Feng Peng, Ruizhi He, Simiao Xu, Jikuan Jin, Yi Wu, Abula Nuer, Barish Edil, Yu-Wen Tien, Gang Jin, Lei Zheng, Jin He, Jianhua Liu, Yahui Liu, Min Wang, Renyi Qin. Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumorsHPB 2022; 24(5): 681 doi: 10.1016/j.hpb.2021.10.017
17
Giuseppe Curigliano, Miguel Martin, Komal Jhaveri, J.T. Beck, Giampaolo Tortora, Nicola Fazio, Michela Maur, Richard A. Hubner, Harald Lahner, Valerie Donnet, Olga Ajipa, Zheng Li, Lars Blumenstein, Fabrice Andre. Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre studyEuropean Journal of Cancer 2021; 151: 49 doi: 10.1016/j.ejca.2021.03.042
18
Andrei Havasi, Daniel Sur, Simona Sorana Cainap, Cristian-Virgil Lungulescu, Laura-Ioana Gavrilas, Calin Cainap, Catalin Vlad, Ovidiu Balacescu. Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable BiomarkersInternational Journal of Molecular Sciences 2022; 23(3): 1109 doi: 10.3390/ijms23031109
19
Zhen Yang, Jie Liang, Kaiming Leng, Guangjun Shi. Survival Benefit of Surgical Resection for Pancreatic Neuroendocrine Tumors With Oligometastatic Liver Metastasis: A Retrospective and Propensity Score-Matching AnalysisFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.903560
20
Samuel Frey, Eric Mirallié, Maëlle Le Bras, Nicolas Regenet. What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative ReviewCancers 2021; 13(23): 5954 doi: 10.3390/cancers13235954
21
Li Quan, Yongkang Liu, Wenjing Cui, Xinru Wang, Weixiao Zhang, Zhongqiu Wang, Chuangen Guo, Chao Lu, Feixiang Hu, Xiao Chen. The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasmsLipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01669-z
22
Miłosz Caban, Ewa Małecka-Wojciesko. Pancreatic IncidentalomaJournal of Clinical Medicine 2022; 11(16): 4648 doi: 10.3390/jcm11164648
23
Olesja Rogoza, Kaspars Megnis, Marija Kudrjavceva, Aija Gerina-Berzina, Vita Rovite. Role of Somatostatin Signalling in Neuroendocrine TumoursInternational Journal of Molecular Sciences 2022; 23(3): 1447 doi: 10.3390/ijms23031447
24
Hai-Yan Chen, Yao Pan, Jie-Yu Chen, Lu-lu Liu, Yong-Bo Yang, Kai Li, Ri-Sheng Yu, Guo-Liang Shao. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomasEuropean Radiology 2022;  doi: 10.1007/s00330-022-08891-4
25
Aldona Kasprzak. Somatostatin and Its Receptor System in Colorectal CancerBiomedicines 2021; 9(11): 1743 doi: 10.3390/biomedicines9111743
26
Cornelius J Fernandez, Mayuri Agarwal, Biju Pottakkat, Nisha Nigil Haroon, Annu Susan George, Joseph M Pappachan. Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshotWorld Journal of Gastrointestinal Surgery 2021; 13(3): 231-255 doi: 10.4240/wjgs.v13.i3.231
27
G. Vivanet, L. Gervaso, A. Laffi, M. Rubino, F. Spada, N. Fazio. Ten years-experience of sunitinib in the treatment of advanced pan-NETs: an update on safety profileExpert Opinion on Drug Safety 2022; 21(3): 303 doi: 10.1080/14740338.2022.2000964
28
Zhen Yang, Guangjun Shi. Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER databaseEuropean Journal of Surgical Oncology 2022;  doi: 10.1016/j.ejso.2022.05.016
29
Xi-Tai Huang, Jin-Zhao Xie, Chen-Song Huang, Jian-Hui Li, Wei Chen, Li-Jian Liang, Xiao-Yu Yin. Development and validation of nomogram to predict lymph node metastasis preoperatively in patients with pancreatic neuroendocrine tumorHPB 2022;  doi: 10.1016/j.hpb.2022.08.015
30
Andrew Canakis, Linda S Lee. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasmsWorld Journal of Gastrointestinal Endoscopy 2022; 14(5): 267-290 doi: 10.4253/wjge.v14.i5.267
31
Rafał Stankiewicz, Michał Grąt. Current status of surgical management of patients with gastroenteropancreatic neuroendocrine neoplasmsWorld Journal of Gastrointestinal Surgery 2022; 14(4): 276-285 doi: 10.4240/wjgs.v14.i4.276
32
Darryl Mason, Robert Leimbach, Robert Kitz, Robert Vietor, Nicole Vietor. Calcitonin‐secreting pancreatic neuroendocrine tumor in a patient with elevated thyroid fine‐needle aspirate calcitonin washout: A case report and review of the literatureClinical Case Reports 2022; 10(1) doi: 10.1002/ccr3.5296
33
Wu-Hu Zhang, He-Li Gao, Wen-Sheng Liu, Yi Qin, Zeng Ye, Xin Lou, Fei Wang, Yue Zhang, Xue-Min Chen, Jie Chen, Xian-Jun Yu, Qi-Feng Zhuo, Xiao-Wu Xu, Shun-Rong Ji. A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survivalFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.941210
34
Maja Cigrovski Berkovic, Monika Ulamec, Sonja Marinovic, Ivan Balen, Anna Mrzljak. Malignant insulinoma: Can we predict the long-term outcomes?World Journal of Clinical Cases 2022; 10(16): 5124-5132 doi: 10.12998/wjcc.v10.i16.5124